StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4925.T$1708.00+0.18%
Fair $1708.00+0.0%

4925.T

HABA Laboratories,Inc.

Consumer Defensive / Household & Personal ProductsTokyo

$1708.00

+3.00 (+0.18%)

Fairly Valued+0.0%Fair Value $1708.00Fund rank 28/100 · Data gapFallback financials|
SA 39/D
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-232.7M · quality 48.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

39/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 4925.TLocal privado en este navegador · HABA Laboratories,Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$6.5B

P/E

8.5x

↓

EV/EBITDA

4.4x

↓

ROE

6.5%

↓

Gross Margin

67.1%

↑

Debt/Equity

0.20

↓
52-Week Range$1708
$1609$1849

TradingView lightweight chart

4925.T price, volumen y niveles de valoración

Último $1,708Periodo -65.8%
Fair value: $1,708

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-2.2%

FCF CAGR

-2.6%

FCF margin

11.7%

FCF / Net income

2.44x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $12.06B · net income $576.6M · FCF $1.41B

2022-FY → 2025-FY

Gross margin

67.1%-1.0% pts

Operating margin

4.9%+7.3% pts

Net margin

4.8%+6.9% pts

FCF margin

11.7%-0.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$12.06B$12.06B$12.32B$12.04B$12.91B
Net Income$576.6M$576.6M$-2.12B$-707.9M$-269.0M
EBITDA$811.6M$811.6M$-1.31B$17.0M$448.3M
EPS152.47152.47-560.26-187.19-71.14
Gross Margin67.1%67.1%68.2%67.9%68.1%
Operating Margin4.9%4.9%-1.5%-5.1%-2.5%
Net Margin4.8%4.8%-17.2%-5.9%-2.1%
Balance Sheet
Debt/Equity0.200.200.280.190.22
Current Ratio4.174.17———
Cash Flow
Free Cash Flow$1.41B$1.41B$-1.02B$-232.7M$1.53B
Returns
ROE6.5%6.5%-24.9%-6.6%-2.3%
Valuation
P/E8.508.50———
EV/EBITDA4.354.35—354.1610.94
P/B0.720.720.920.820.69
Growth & Yield
Revenue Growth-2.1%-2.1%2.4%-6.7%—
EPS Growth127.2%127.2%-199.3%-163.1%—
Dividend Yield2.4%2.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-0.2%

fácil

EPS terminal req.

$151.56

Spread vs growth

127.4%

5Y implied EPS CAGR

3.8%

fácil

EPS terminal req.

$183.38

Spread vs growth

123.5%

10Y implied EPS CAGR

6.8%

razonable

EPS terminal req.

$295.34

Spread vs growth

120.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +2.1%

Total return

+2.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-560.26 → 152.47

Residual

-0.2%

EPS growthn/d
Multiple reratingn/d
Dividend+2.4%
Residual / FX / buybacks / cross-term-0.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.